Patient Stories
What patients are saying…
I highly recommend the use of StoreMyTumor to every patient!
– Pam Duffy
I preserved my tumor for a specific clinical trial, but as I was waiting for it, I was disqualified. I was devastated at first, but thankfully learned that the same treatment was available in Germany.
My son made sure I had sight-seeing adventures every day after my treatment was finished. We had a great time!! Thanks for making this happen!!
– Carrie Gillotte
Now, facing a second surgery, I want to make sure to harvest tissue for more current immunotherapy treatments.
Every woman should be given this choice because there are no do-overs
– Judy McCann
Janet Richards
All the exciting research I found for ovarian cancer treatments focuses on vaccine trials treatments (a type of personalized immunotherapy), which, in most cases, require fresh tissue.
If a patient is lucky to travel and do the surgery at the academic center conducting the clinical trial, they might store the tissue for the patient and for the particular trial, but they also generally own all the tissue whether it is used by the patient or not.
Store My Tumor gives patients options to have the surgery performed in a location different from the vaccine trial location; to store one’s tumor at the time of the original debulking in case it might be needed for future trials; and to have control over unused tissue that can be saved for future treatments after the vaccine trial.
In my own case, Store My Tumor was not an available option at the time of my initial debulking surgery in 2002 or at the time of my operation for my first recurrence in 2008. Only paraffin slides were saved from those surgeries, which is the protocol at most hospitals. When I recurred again in 2010, I was told by docs at Sloan Kettering and MD Anderson that the spots on my liver were inoperable. In 2013, I found Dr. Javier Magrina at the Mayo Clinic in Phoenix who agreed to operate. For several years I had wanted to get into the vaccine trials at UPenn but did not have the live tissue required. I immediately phoned UPenn to see if they would accept the tissue from the Mayo surgery. They agreed on the condition that the tumor was properly processed and transported. UPenn had worked previously with Store My Tumor and approved of my using their services.
“The collection was a simple procedure from my standpoint” Dr. Magrina said; Store My Tumor delivered a box to my hotel the day before the surgery; I took it with me to the hospital on the morning of the surgery; medical personnel gave the box back to my son following surgery; he dropped it off at FedEx. Done!
After I recovered from surgery, I contacted UPenn and began the process of testing to determine my eligibility for the trial. Only when I was admitted to the trial did I tell Store My Tumor to release my tissue to UPenn. I released only the amount required for the vaccine trial. The rest of my tissue is still stored at Store My Tumor in case I need it for future treatments or diagnostics.
I believe access to one’s own tissue will give ovarian (and all patients) many more personalized treatment options for assay testing, targeted therapies, and vaccine trials. I am so glad to have had the option to receive surgery in Phoenix (next to my home), participate in the vaccine trial at UPenn, and still have more tissue stored that I can access for future treatment if needed.
– Jeanne
– Edna
– John
Not just the tumor storage but the education I received from StoreMyTumor about cancer vaccines and clinical trials was worth every penny! I didn’t get that from my doctor. I feel so much better prepared to fight this. I am just not ready to leave my daughter.
– Marcia
– Laurence
– Pam
Disclaimer: patients’ original names and photos above were replaced to protect patients’ privacy
TRUE STORIES OF IMMUNOTHERAPY
Diagnosed with breast cancer in 2010, Melissa Nicholas was treated with a personalized vaccine, with the intent of preventing a recurrence of her cancer.
– Melissa
Diagnosed with melanoma in 2009, Hein Jambroers was treated with a combination of TILs (Tumor-infiltrating Lymphocytes) and immunotherapy drugs.
– Hein
Ray Merrill was diagnosed with melanoma in 2011. Standard of care treatments did not work, so he was treated with a dendritic cell vaccine specifically for his tumor.
– Ray
Diagnosed with ovarian cancer in 2007, Liz Thomasson was treated with personalized cancer vaccine to prevent future cancer, through a clinical trial.
– Liz
Diagnosed with ovarian cancer stage 3 in 2009, Yi Zuo was treated with a personalized cancer vaccine to prevent recurrence, through a clinical trial.
– Yi
Ray Merrill was diagnosed with melanoma in 2011. Standard of care treatments did not work, so he was treated with a dendritic cell vaccine specifically for his tumor.
– Tj
EXPERIENCES WITH ADVANCED DIAGNOSTICS
Diagnosed with breast cancer in 1992 with a recurrence in 2003, including multiple metastases, Sandy Fehrman was treated with therapies directed by molecular profiling of her specific tumor.
– Sandy
Diagnosed with sarcoma in 2010, Yaron was treated with a regimen determined by a mouse TumorGraft.
– Yaron
Diagnosed with ovarian cancer in 1999 with a life expectancy of weeks to months, Elizabeth Panke was treated with a very specific combination of drugs determined by chemosensitivity testing.
– Elizabeth